14 NASDAQ Growth Stocks With Bullish Moving Averages

Recent Performance of the Stocks Mentioned Below:

Average 1-Week Return: 0.67%
Average 1-Month Return: -4.55%
Average 1-Year Return: 126.2%

1. Ariad Pharmaceuticals Inc. (ARIA). Focuses on the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. Earnings per share expected to grow by 25% over the next five years. SMA50 at $22.91 vs. SMA200 at $18.32.

2. ARM Holdings plc (ARMH). ARM Holdings plc and its subsidiaries design microprocessors, physical IP, and related technology and software, as well as sells development tools to enhance the performance of high-volume embedded applications. Earnings per share expected to grow by 18.1% over the next five years. SMA50 at $29.6 vs. SMA200 at $26.59.

3. Arena Pharmaceuticals, Inc. (ARNA). Focuses on discovering, developing, and commercializing oral drugs in the therapeutic areas of cardiovascular, central nervous system, inflammatory, and metabolic diseases. Earnings per share expected to grow by 25% over the next five years. SMA50 at $8.6 vs. SMA200 at $6.33.

4. BioMarin Pharmaceutical Inc. (BMRN). Develops and commercializes biopharmaceuticals for serious diseases and medical conditions. Earnings per share expected to grow by 36% over the next five years. SMA50 at $41.38 vs. SMA200 at $38.05.

5. Avis Budget Group, Inc. (CAR). Provides car and truck rentals, and ancillary services to businesses and consumers in the United States and internationally. Earnings per share expected to grow by 18.25% over the next five years. SMA50 at $16.6 vs. SMA200 at $14.97.

6. Comcast Corporation (CMCSA). Provides entertainment, information, and communications products and services in the United States and internationally. Earnings per share expected to grow by 15.56% over the next five years. SMA50 at $35.91 vs. SMA200 at $31.65.

7. Gilead Sciences Inc. (GILD). Engages in the discovery, development, and commercialization of therapeutics for the treatment of life threatening diseases worldwide. Earnings per share expected to grow by 17% over the next five years. SMA50 at $66.64 vs. SMA200 at $54.89.

8. LKQ Corp. (LKQ). Earnings per share expected to grow by 20.1% over the next five years. SMA50 at $19.91 vs. SMA200 at $17.72.

9. Mellanox Technologies, Ltd. (MLNX). Engages in the design, development, marketing, and sale of interconnect products primarily in North America, Israel, Europe, and Asia. Earnings per share expected to grow by 69.33% over the next five years. SMA50 at $94.98 vs. SMA200 at $71.73.

10. Onyx Pharmaceuticals, Inc. (ONXX). Engages in developing therapies targeting the molecular mechanisms causing cancer in the United States and internationally. Earnings per share expected to grow by 37.38% over the next five years. SMA50 at $81.6 vs. SMA200 at $59.09.

11. SIRIUS XM Radio Inc. (SIRI). Provides satellite radio services in the United States and Canada. Earnings per share expected to grow by 27.87% over the next five years. SMA50 at $2.68 vs. SMA200 at $2.29.

12. Sarepta Therapeutics, Inc. (SRPT). Earnings per share expected to grow by 20% over the next five years. SMA50 at $22.11 vs. SMA200 at $10.3.

13. Smith & Wesson Holding Corporation (SWHC). Offers metal processing services and manufactures firearms and handcuffs as well as apparel and sportsmen’s articles. Earnings per share expected to grow by 22% over the next five years. SMA50 at $10.17 vs. SMA200 at $8.16.

14. Urban Outfitters Inc. (URBN). Operates lifestyle specialty retail stores under the Urban Outfitters, Anthropologie, Free People, Terrain, Leifsdottir, and BHLDN brands. Earnings per share expected to grow by 17.41% over the next five years. SMA50 at $37.39 vs. SMA200 at $31.21.